This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Jim Cramer's 'Mad Money' Recap: 5 Groups You Once Loved but Now Hate

Cramer says these five groups must be approached with caution.

'Mad Money' Lightning Round: IBM Is Getting Attractive

Cramer says Radius Health is terrific but Blue Buffalo Pet Products is expensive compared to its growth rate.

Jim Cramer's Top Takeaways: Eli Lilly, Caterpillar, Opko Health

Eli Lilly is better than the market thinks, Cramer says. He's a believer in Opko Health but would avoid Caterpillar.

Jim Cramer's 'Mad Money' Recap: Don't Take It Personal but Your Stocks Are Going Down

It's not that you haven't picked great stocks, the market just stinks and is acting irrationally, Cramer confides.

Jim Cramer's 'Mad Money' Recap: Why Small Private Companies Should Be on Your Radar

Up-and-coming private companies are 'disruptors' that can take on their publicly traded peers like an oncoming train, Cramer says.

'Mad Money' Lightning Round: Buy, Buy, Buy Terrific Dow Chemical

Cramer is in no hurry to buy Gilead Sciences right now and is no fan of Corning.

Jim Cramer's Top Takeaways: Tyler Technologies, Honeywell, General Mills

Cramer says Tyler Technologies is a solid performer while Honeywell and General Mills are the running backs for his fantasy stock portfolio team.

Jim Cramer's 'Mad Money' Recap: Here's Where to Find Stock Bargains Now

There are bargains out there in a number of sectors, Cramer says. You just have to know where to look.

'Mad Money' Lightning Round: Consolidated Edison Is Great

Cramer says the selloff in Lululemon was overdone but be careful on Northern Tier Energy.

Jim Cramer's Top Takeaways: Allergan, Randgold, La Quinta

Cramer is solidly behind Allergan but admits he got it wrong on La Quinta.

Page 2 of 401
Top Rated Stocks Top Rated Funds Top Rated ETFs